Model of the developing tumorigenic phenotype in mammalian cells and the roles of sustained stress and replicative senescence.

The molecular mechanisms that drive mammalian cells to the development of cancer are the subject of intense biochemical, genetic and medical studies. But for the present, there is no comprehensive model that might serve as a general framework for the interpretation of experimental data. This paper is an attempt to create a conceptual model of the mechanism of the developing tumorigenic phenotype in mammalian cells, defined as having high genomic instability and proliferative activity. The basic statement in the model is that mutations acquired by tumor cells are not caused directly by external DNA damaging agents, but instead are produced by the cell itself as an output of a Mutator Response similar to the bacterial "SOS response" and characterized by the initiation of error-prone cell cycle progression and an elevated rate of mutation. This response may be induced in arrested mammalian cells by intracellular and extracellular proliferative signals combined with blocked apoptosis. The mutant cells originated by this response are subjected to natural selection via apoptosis and turnover. This selection process favors the survival of cells with high proliferative activity and the suppression of apoptosis resulting in the long run in the appearance of immortalized cells with high proliferative activity. Either a sustained stressful environment accompanied by continuing apoptotic cell death, or replicative senescence, provides conditions suitable for activation of the Mutator Response, namely the emergence of arrested cells with blocked apoptosis and the induction of proliferative signal. It also accelerates the selection process by providing continuing cell turnover. The proposed mechanism is described at the level of involved metabolic pathways and proteins and substantiated by the related experimental data available in the literature.

[1]  R. DePinho,et al.  Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. , 2003, Genes & development.

[2]  B. Hall,et al.  Adaptive mutations in Escherichia coli as a model for the multiple mutational origins of tumors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Z. Humayun,et al.  SOS and Mayday: multiple inducible mutagenic pathways in Escherichia coli , 1998, Molecular microbiology.

[4]  B. Bridges Starvation-associated mutation in Escherichia coli: a spontaneous lesion hypothesis for "directed" mutation. , 1994, Mutation research.

[5]  R. Chetty,et al.  Cyclin E in human cancers , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  B. Ames,et al.  The causes and prevention of cancer: gaining perspective. , 1997, Environmental health perspectives.

[7]  T. Helleday,et al.  Different Roles for Nonhomologous End Joining and Homologous Recombination following Replication Arrest in Mammalian Cells , 2002, Molecular and Cellular Biology.

[8]  R. DePinho,et al.  p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Shilo,et al.  Regulation of cell number by MAPK-dependent control of apoptosis: a mechanism for trophic survival signaling. , 2002, Developmental cell.

[10]  J. Roth,et al.  Amplification–mutagenesis: Evidence that “directed” adaptive mutation and general hypermutability result from growth with a selected gene amplification , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Y. Zou,et al.  Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. , 1997, The Journal of clinical investigation.

[12]  R. Woodgate A plethora of lesion-replicating DNA polymerases. , 1999, Genes & development.

[13]  M. Rao,et al.  Neural stem cells and regulation of cell number , 2002, Progress in Neurobiology.

[14]  Timothy K Starr,et al.  Positive and negative selection of T cells. , 2003, Annual review of immunology.

[15]  S. Wacholder,et al.  Interpreting epidemiologic research: lessons from studies of childhood cancer. , 2003, Pediatrics.

[16]  S. Kowalczykowski,et al.  The DNA binding and pairing preferences of the archaeal RadA protein demonstrate a universal characteristic of DNA strand exchange proteins , 2000, Molecular microbiology.

[17]  J. Overbaugh,et al.  The origin of mutants , 1988, Nature.

[18]  Z. Wang DNA damage-induced mutagenesis : a novel target for cancer prevention. , 2001, Molecular interventions.

[19]  L. Chin,et al.  Telomere dysfunction provokes regional amplification and deletion in cancer genomes. , 2002, Cancer cell.

[20]  R. Dickson,et al.  c-Myc alters the DNA damage-induced G2/M arrest in human mammary epithelial cells , 2003, British Journal of Cancer.

[21]  R. Abe,et al.  Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts. , 2000, Biochimica et biophysica acta.

[22]  J. Sample,et al.  Epstein-Barr Virus Regulates c-MYC, Apoptosis, and Tumorigenicity in Burkitt Lymphoma , 1999, Molecular and Cellular Biology.

[23]  S. R. Datta,et al.  Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. , 1999, Science.

[24]  R. Schaaper,et al.  Genetic requirements and mutational specificity of the Escherichia coli SOS mutator activity , 1997, Journal of bacteriology.

[25]  E. Blackburn,et al.  Telomeres, telomerase and cancer. , 1996, Scientific American.

[26]  R. Margolis,et al.  Chemical induction of mitotic checkpoint override in mammalian cells results in aneuploidy following a transient tetraploid state. , 1996, Mutation research.

[27]  W. Morgan,et al.  Polymerase eta deficiency in the xeroderma pigmentosum variant uncovers an overlap between the S phase checkpoint and double-strand break repair. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  David Botstein,et al.  Characteristic genome rearrangements in experimental evolution of Saccharomyces cerevisiae , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  G. Carruba,et al.  Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor. , 1995, Endocrinology.

[30]  W C Willett,et al.  The causes and prevention of cancer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Mark J. Murphy,et al.  c-Myc regulates mammalian body size by controlling cell number but not cell size , 2001, Nature.

[32]  G. Evan,et al.  Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.

[33]  S. Korsmeyer,et al.  Apoptosis in the development and maintenance of the immune system , 2003, Nature Immunology.

[34]  Kenneth J. Hillan,et al.  Angiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1 , 2003, Science.

[35]  R. Weinberg,et al.  Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. , 2003, Cancer cell.

[36]  S. Kowalczykowski,et al.  DNA strand exchange proteins: a biochemical and physical comparison. , 1998, Frontiers in bioscience : a journal and virtual library.

[37]  Yanbin Zhang,et al.  Two-step error-prone bypass of the (+)- and (−)-trans-anti-BPDE-N2-dG adducts by human DNA polymerases η and κ , 2002 .

[38]  P. Pandolfi,et al.  Activation of Akt/Protein Kinase B Overcomes a G2/M Cell Cycle Checkpoint Induced by DNA Damage , 2002, Molecular and Cellular Biology.

[39]  R. Zeillinger,et al.  Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines. , 2003, International journal of oncology.

[40]  B. Amati,et al.  Cyclin E and c‐Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins , 1997, The EMBO journal.

[41]  L. Harrington,et al.  Telomeres, telomerase, and cancer: life on the edge of genomic stability , 2000, Current opinion in oncology.

[42]  Localisation of human DNA polymerase κ to replication foci , 2002, Journal of Cell Science.

[43]  L. Stanton,et al.  Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells , 1986, Molecular and cellular biology.

[44]  J. Pietenpol,et al.  Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. , 2002, Toxicology.

[45]  C. Der,et al.  Understanding Ras: 'it ain't over 'til it's over'. , 2000, Trends in cell biology.

[46]  Pascal Meier,et al.  Apoptosis in development , 2000, Nature.

[47]  N. Rosenberg,et al.  p53 Mediates Apoptotic Crisis in Primary Abelson Virus-Transformed Pre-B Cells , 1999, Molecular and Cellular Biology.

[48]  J. Sedivy,et al.  A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation. , 2001, Cancer research.

[49]  N. Restifo,et al.  Natural selection of tumor variants in the generation of “tumor escape” phenotypes , 2002, Nature Immunology.

[50]  Martin Raff,et al.  Cell suicide for beginners , 1998, Nature.

[51]  D. Dykhuizen Chemostats used for studying natural selection and adaptive evolution. , 1993, Methods in enzymology.

[52]  P. Hall,et al.  Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. , 1994, Journal of cell science.

[53]  L. Vatten,et al.  Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis , 2001, British Journal of Cancer.

[54]  J. Shay,et al.  Telomeres and Telomerase: Implications for Cancer and Aging , 2001, Radiation research.

[55]  R. Eisenman,et al.  The Myc/Max/Mad network and the transcriptional control of cell behavior. , 2000, Annual review of cell and developmental biology.

[56]  E. Ortega,et al.  Oncogenic H-ras induces cyclin B1 expression in a p53-independent manner. , 2002, Mutation research.

[57]  N. Yamada,et al.  Induction of a low level of microsatellite instability by overexpression of DNA polymerase Beta. , 2002, Cancer research.

[58]  Robert A. Weinberg,et al.  Creation of human tumour cells with defined genetic elements , 1999, Nature.

[59]  C. Lawrence,et al.  Eukaryotic mutagenesis and translesion replication dependent on DNA polymerase ζ and Rev I protein , 2001 .

[60]  C. Longcope,et al.  Serum sex hormones and breast cancer risk factors in postmenopausal women. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[61]  W. Coleman,et al.  The Molecular Basis of Human Cancer , 2002, Humana Press.

[62]  D. Stupack,et al.  Role of Raf in Vascular Protection from Distinct Apoptotic Stimuli , 2003, Science.

[63]  T. Kunkel,et al.  Functions of human DNA polymerases η, κ and ι suggested by their properties, including fidelity with undamaged DNA templates , 2003 .

[64]  S. Rodin,et al.  Human lung cancer and p53: the interplay between mutagenesis and selection. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[65]  R. Weinberg,et al.  Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts , 1986, Molecular and cellular biology.

[66]  L. Mullenders,et al.  Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells. , 2001, Genes & development.

[67]  F. McCormick,et al.  Opposing Effects of Ras on p53 Transcriptional Activation of mdm2 and Induction of p19ARF , 2000, Cell.

[68]  S. Rosenberg,et al.  Adaptive mutations, mutator DNA polymerases and genetic change strategies of pathogens. , 2001, Current opinion in microbiology.

[69]  Rey-Huei Chen,et al.  Molecular interpretation of ERK signal duration by immediate early gene products , 2002, Nature Cell Biology.

[70]  Sergey V. Balashov,et al.  Mistranslation induced by streptomycin provokes a RecABC/RuvABC-dependent mutator phenotype in Escherichia coli cells. , 2002, Journal of molecular biology.

[71]  D. Laskin,et al.  The ribotoxic stress response as a potential mechanism for MAP kinase activation in xenobiotic toxicity. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[72]  N. Mailand,et al.  Involvement of Myc Activity in a G1/S-Promoting Mechanism Parallel to the pRb/E2F Pathway , 2000, Molecular and Cellular Biology.

[73]  M. Goodman Error-prone repair DNA polymerases in prokaryotes and eukaryotes. , 2002, Annual review of biochemistry.

[74]  C. Kisker,et al.  Error-Prone DNA Polymerases Novel Structures and the Benefits of Infidelity , 2001, Cell.

[75]  D. Sharma,et al.  MODULATION OF C‐ MYC AND C‐ FOS GENE EXPRESSION IN REGENERATING RAT LIVER BY 2‐MERCAPTOPROPIONYLGLYCINE , 2002, Cell biology international.

[76]  F. O. Fackelmayer,et al.  DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. , 2001, Cancer research.

[77]  J. Steitz,et al.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. , 1992, The EMBO journal.

[78]  D. Green,et al.  The machinery of programmed cell death. , 2001, Pharmacology & therapeutics.

[79]  Chikahide Masutani,et al.  Low fidelity DNA synthesis by human DNA polymerase-η , 2000, Nature.

[80]  S. Reed,et al.  Cyclin E-induced S phase without activation of the pRb/E2F pathway. , 1997, Genes & development.

[81]  C. Der,et al.  Increasing complexity of Ras signal transduction: involvement of Rho family proteins. , 1998, Advances in cancer research.

[82]  M. Merville,et al.  Roles of nuclear factor-kappaB, p53, and p21/WAF1 in daunomycin-induced cell cycle arrest and apoptosis. , 2000, The Journal of pharmacology and experimental therapeutics.

[83]  G. Nossal The double helix and immunology , 2003, Nature.